Academics

Impact of
a Blended Plant Protein Supplement on Resistance Training Adaptations

Impact of
a Blended Plant Protein Supplement on Resistance Training Adaptations

Academics NAVIGATION

LU IRB#: IRB-22-44
PI: Chad Kerksick, PhD

Description of Study

The aim of the research study is to examine the effect of plant protein on resistance training adaptations.

Location
Exercise and Performance Nutrition Laboratory (Fieldhouse 126)
209 S. Kingshighway
St. Charles, MO 63301

Number of Visits
3

Time Commitment
Visits 1: 30-45 Minutes
Visits 2-3: 120 Minutes Each

Compensation
$300 (Direct Deposit)

Point of Contact
Logan Orr
epnl@lindenwood.edu

Research Sample Needed

  • 24 active men and women

Inclusion Criteria

  • Provide voluntary signed and dated informed consent.
  • Be in good health as determined by medical history and routine blood chemistries.
  • Between the ages of 18 and 55.
  • Body Mass Index of 18.5-29.9.
  • Bodyweight of at least 120 pounds.
  • Normotensive (seated, resting systolic blood pressure <140 mm Hg and diastolic blood pressure < 90 mm Hg.
  • Normal seated, resting heart rate (<90 per minute).
  • Willing to follow all study protocols.

Exclusion Criteria

  • Diagnosed with liver, renal, cardiovascular, or other metabolic diseases.
  • Use of any dietary supplements which may confound the study or its endpoints, including creatine, BCAA, HMB, betaine, beta-alanine, etc.
  • Alcohol consumption (>2 standard alcoholic drinks per day or >10 drinks per week) or drug abuse or dependence.
  • Smokers or individuals who have quit smoking within the last 6 months.
  • Clinically significant abnormal laboratory results at screening.
  • Known sensitivity to any ingredient in the test formulations.
  • Individuals who are cognitively impaired and/or who are unable to give informed consent.
  • Chronic inflammatory condition or disease (e.g., rheumatoid arthritis, gout, fibromyalgia, Crohn’s disease, ulcerative colitis, Lupus, HIV/AIDS, etc.).
  • History of diabetes.
  • Other known gastrointestinal or metabolic diseases that might impact nutrient absorption or metabolism, e.g., short bowel syndrome, diarrheal illnesses, history of colon resection, gastro paresis, Inborn-Errors-of-Metabolism (such as PKU).
  • Individuals with excessive caffeine intake (>300mg/serving or 600mg/day).
  • Take medication that may adversely affect measured outcomes (i.e., testosterone or other anabolic steroids, diuretics, etc.).
  • History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin).
  • Prior gastrointestinal bypass surgery (i.e., Lapband, etc.).
  • Pregnant women, women trying to become pregnant, or nursing women.
  • Currently participating in another research study with an investigational product or have been in another research study in the past 30 days.
  • Concomitant use of corticosteroids or testosterone replacement therapy (ingestion, injection, or transdermal).
  • Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose a significant risk to the subject.

Are You Eligible?

Information provided here reflects current IRB approval for this research. However, this information may be subject to change and updated accordingly.